An 83-year-old man is brought to the emergency department (ED) for treatment of fever and altered mental status. The patient resides in a skilled nursing facility (SNF) and was brought to the ED because of a one-week history of increasing agitation and urinary urgency and a one-day history of shaking chills and confusion; the caregiver reports that his urine has been foul-smelling. There is no report of head trauma. The patient has a history of mild Alzheimer's dementia, hypertension, and intermittent anxiety. Medications are donepezil (10 mg daily), paroxetine (20 mg daily), hydrochlorothiazide (25 mg daily), diphenhydramine (25 mg four times daily as needed), and oxybutynin (5 mg three times daily). On admission to the ED, his temperature is 37°C (98.6°F), pulse is 92⁄min, respirations are 18⁄min, and blood pressure is 110⁄70 mm Hg. He is lethargic and unable to answer questions. Neurologic examination shows no focal findings. Blood is drawn, and urine is collected for analysis and culture.
Sign in to take quiz and track your certificates
To help improve the quality of its educational content and meet applicable education accreditation requirements, the content provider will receive record of your participation and responses to this activity.
The American Geriatrics Society (AGS) is a not-for-profit society dedicated to improving the health, independence and quality of life of older people.
Module not playing? Click here
Copyright 2020 by the American Geriatrics Society and the American Board of Medical Specialties. All rights reserved.
All content in this Site, including site layout, design, images, programs, text, and other information (collectively, the “Content”) is the property of the American Geriatrics Society (AGS) and is protected by copyright and other intellectual property laws.
You may not copy, display, reproduce, retransmit, store, distribute, disseminate, modify, publish, broadcast, circulate, create derivative works from, or sell or license any part of the Content, products, or services obtained from this Site in any medium to anyone, including but not limited to others in the same company or organization, without the express prior written permission of AGS, except as otherwise expressly permitted under applicable law or as described in these Terms and Conditions or relevant license or subscriber agreement.
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Geriatrics Society and the American Board of Medical Specialties. The American Geriatrics Society is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement: The American Geriatrics Society designates this enduring continuing medical educational activity for a maximum of 0.25 AMA PRA Category 1 Credits™.
Release Date: 10/14/2021
Expiration Date: 02/01/2024
Financial Disclosure Statement: As an ACCME accredited provider of Continuing Medical Education, the American Geriatrics Society must ensure balance, independence, objectivity and scientific rigor in all of our educational activities. We have implemented a process wherein everyone who is in a position to control the content of an education activity has disclosed to us all financial relationships with ineligible company within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. AGS then reviews the disclosure information to determine which financial relationships are relevant and mitigates relevant financial relationships with ineligible companies to prevent commercial bias in the content.
The following members of the advisory panel had no relevant financial relationships with ineligible companies to disclose:
• Ruben Azocar, MD
• George Drach, MD
• Sandhya Lagoo-Deenadayalan, MD, PhD
• Andrew Lee, MD
• Mike Malone MD
• Myron Miller, MD
• Arvind Nana, MD
• Tom Robinson, MD
• Victoria Tang MD, MAS
The following members of the advisory panel have reported relevant financial relationships with ineligible companies that have been mitigated through peer review of planning decisions by persons without relevant financial relationships and recusal from any aspect of planning and content related to the financial relationship:
• Kevin Biese MD, MAT is a paid consultant for Call 9 Telemedicine Medical Advisor and Bristol Meyers Squibb/ Pfizer
• Daniel Mendelson, MS, MD is a paid consultant for Point Click Care Touchscreen
The following members of the writing panel had no relevant financial relationships with ineligible companies to disclose:
• Tomas Griebling, MD
• Joseph Hejkal, MD
• Melissa Hornor, MD
• Jason Johanning, MD
• Sushila Murthy, MD, MPH
• Tony Rosen, MD, MPH
• Kate Schenning, MD, MPH
The following members of the writing panel have reported relevant financial relationships with ineligible companies that have been mitigated through peer review of content by persons without relevant financial relationships:
• Charles Brown, MD is a paid consultant for and receives grants from Medtronic
• Badrinath Konety, MD, MBA is a paid consultant for NxThera, and Bristol Myers Squibb, Opko and receives grant funding from Photocure, Genentech, and Genomic Health
The following reviewers had no relevant financial relationships with ineligible companies to disclose:
• Shamsuddin Akhtar, MD
• Patrick Kortebein, MD
• Joseph LoCicero, MD
This CME activity is supported by a grant from the John A. Hartford Foundation.
Provider Contact Information
For questions regarding the content of this activity assistance, contact firstname.lastname@example.org or 212-308-1414.
Policy on Privacy and Confidentiality
You currently have no searches saved.
You currently have no courses saved.